United States v. Sene X Eleemosynary Corp., Inc.
Decision Date | 29 October 1979 |
Docket Number | No. 79-2661-Civ-SMA.,79-2661-Civ-SMA. |
Citation | 479 F. Supp. 970 |
Parties | UNITED STATES of America, Plaintiff, v. SENE X ELEEMOSYNARY CORP., INC., a corporation, also doing business as "Club SeneX"; and, Seven Freedom Pharmacy, Inc., a corporation; and Alan M. Kratz, Harry Emerson, and Roger I. Sabastier, Individuals, Respondents. |
Court | U.S. District Court — Southern District of Florida |
COPYRIGHT MATERIAL OMITTED
J. V. Eskenazi, U. S. Atty., Kenneth D. Stern, Asst. U. S. Atty., Southern District of Florida, Miami, Fla., Catherine L. Copp, U. S. Food & Drug Administration, Rockville, Md., Anita Johnson, Consumer Affairs Section, Dept. of Justice, Washington, D. C., for plaintiff.
Richard J. Hays, Theodore J. Silver, Miami, Fla., for respondents.
The following Opinion and Order of Preliminary Injunction constitute findings of fact and conclusions of law for the purposes of Rule 52(a), Federal Rules of Civil Procedure.
This is an injunction action brought pursuant to section 302(a) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 332(a) (the Act), which grants federal district courts jurisdiction to restrain violations of section 301 of the Act, 21 U.S.C. § 331. The corporate defendants are Sene X Eleemosynary Corporation, Inc. (Sene X Corp.), 5400 Northwest 159th Street, Miami, Florida, also doing business as Club SeneX, and Seven Freedom Pharmacy, Inc., 2125 Stirling Road, Fort Lauderdale, Florida, both corporations organized and existing under the laws of the State of Florida. The individual defendants are Alan M. Kratz, President and Executive Director of Sene X Corp., Harry Emerson, Vice President and a director of Sene X Corp., and Roger I. Sabastier, a registered pharmacist and President and a director of Seven Freedom Pharmacy.
On June 19, 1979, the plaintiff filed a Complaint for Injunction, charging that the individual and corporate defendants have violated, and continue to violate, sections 301(a), 301(d), and 301(k) of the Act, 21 U.S.C. §§ 331(a), 331(d), and 331(k), in that their activities involve violations of sections 502(a), 505(a), and 502(f)(1) of the Act, 21 U.S.C. §§ 352(a), 355(a), and 352(f)(1). In essence, the Complaint alleges that the defendants are engaged in an operation to compound, promote, and distribute the product, "GH-3 (Equivalent)", an orally administered solution of buffered procaine hydrochloride 2%, as well as GH-3 Topical Cream Formulation, a skin cream. Inasmuch as plaintiff's prayer for relief seeks to enjoin the compounding, promotion, and distribution of GH-3 (Equivalent) or "any similar article of drug" (Complaint at 9), and inasmuch as the testimony establishes that Club SeneX is engaged in the compounding, promotion, and distribution of GH-3 Scalp Fluid, this opinion and Order encompass the defendants' activities with respect to the oral liquid, the skin cream, the scalp fluid, and any other "similar article" of drug, whether or not previously compounded, promoted, or distributed by the defendants.
Regardless of the specific product, the active ingredient in all three of the defendants' products is procaine hydrochloride. Procaine hydrochloride is familiar to the layperson in its use as a local anesthetic, frequently marketed under the proprietary name, Novocaine.
A hearing was held in three segments on July 27, August 24, and September 8, 1979, at which time the Court heard live testimony and admitted into evidence affidavits and documentary exhibits. The plaintiff called five witnesses, three FDA investigators and two medical experts; the defendants offered the testimony of three witnesses, a practicing physician, an attorney who uses defendants' GH-3 oral liquid, and the defendant, Alan M. Kratz. The defendants also offered the deposition testimony of a practicing pharmacist.
The evidence adduced at the hearing demonstrates that the defendants have established and operate Club SeneX, which is based in Miami, Florida, as a means to make their products available throughout the country. The Club is purported to be a non-profit organization, the purpose of which is to disseminate educational information on health and nutrition for the elderly. To obtain any of the defendants' procaine products, an individual must join Club SeneX. In fact, most people join the Club only to obtain the GH-3 products.
To become a Club member, an individual must complete an application for membership, pay membership dues (of one hundred and thirty dollars for a six-month supply of the liquid or sixty dollars for a six-month supply of the cream or the scalp fluid), and procure a written prescription for the product, be it the liquid, cream, or oil. A membership application is included in the booklet written and distributed by Jerome Godin and Samuel Becker, GH-3 Your Prescription for a Healthier Happier Life. (Plaintiff's Exhibit 502c, hereafter PX 502c) A more recent Godin-Becker booklet, GH-3 Discovery, includes directions on how to join Club SeneX. (PX 508c) The written prescription may be obtained from the individual's personal physician or from a physician to whom the individual is referred by Club SeneX and is to be written according to the sample prescription provided both in Club SeneX literature and in the Godin-Becker booklets. (PX 505a) The application, dues, and written prescription must then be mailed to Club SeneX in Miami, Florida.
These items are received on behalf of Club SeneX by defendant Alan Kratz, who delivers the prescriptions to defendant, Roger Sabastier, at Sabastier's Seven Freedom Pharmacy in Fort Lauderdale, Florida. Mr. Sabastier compounds the GH-3 at his pharmacy, utilizing procaine that has been shipped in interstate commerce from Bofors America, in Edison, New Jersey. Dr. Kratz picks up the compounded drug from Seven Freedom Pharmacy, and, with the assistance of Harry Emerson, packages the product with various items of promotional literature. Packages are then delivered to the Club members, usually by United Parcel Service. Records of shipments of GH-3 by Club SeneX via United Parcel Service (PX 313a, 313b, 409a, 409b, 409c, and 409d) establish that the defendants have shipped, or caused to be shipped, their product, GH-3 (Equivalent), in interstate commerce. In addition, there is circumstantial evidence of interstate shipment in the form of GH-3 prescriptions written by doctors practicing outside the State of Florida. (PX 307, 308, and 410.)
The advertisement further states that:
Controlled clinical and laboratory studies conclusively show rejuvenation on all phases of life on which it has been tested from the most simple one celled animals . . . to . . . the most complex of all . . . MAN.
Over the past twelve months, Club SeneX has modified representations in its promotional literature. However, Defendants' Exhibit 5, established to be the most recent literature distributed by Club SeneX, still promotes GH-3 as an effective anti-aging agent. The current literature continues to state that "GH-3, because of its nutritional effect on chronic dis-eases sic such as arthritis, diabetes, hypertension, and cardiovascular conditions, may potentiate the effects of medication(s) being used to treat these dis-eases sic," that "there is solid U.S. scientific research evidence that GH-3 is an effective anti-depressant," and that "The chemical has been found not only to retard the aging process through a...
To continue reading
Request your trial-
Chaney v. Heckler, 82-2321
...to the federal jurisdiction * * * but the fact that the channels of commerce have been used." See also United States v. Sene X Eleemosynary Corp., 479 F.Supp. 970, 981 (S.D.Fla.1979) ("[t]he 'held for sale' standard of section 301 has long been afforded a liberal On appeal, FDA does not foc......
-
US v. 22 Rectangular or Cylindrical Devices
...United States v. An Article of Drug, B-Complex Cholinos Capsules, 362 F.2d 923, 928 (3d Cir.1966); United States v. Sene X Eleemosynary Corp., Inc., 479 F.Supp. 970, 981 (S.D.Fla. 1979). This is particularly true where, as in this case, the cessation of the unlawful acts appears to be a res......
-
US v. Kasz Enterprises, Inc.
...the product, "endorse, and thereby adopt as their own, the statements and representations of others." United States v. Sene X Eleemosynary Corp., 479 F.Supp. 970, 980 (S.D.Fla.1979); United States v. Vital Health Products, Ltd., 786 F.Supp. 761, 776 (E.D.Wis.1992), aff'd, 985 F.2d 563 (7th ......
-
U.S. v. Blue Ribbon Smoked Fish, Inc., CV-01-3887 (CPS).
...that he did not personally participate in manufacture, sale, or distribution of adulterated articles); United States v. Sene X Eleemosynary Corp., 479 F.Supp. 970, 976-77 (S.D.Fla. 1979) (individual defendants' positions of authority and responsibility in the operation states a claim under ......
-
Doing Equity in Bankruptcy
...1994), modified on other grounds, 862 F. Supp. 717 (D.R.I. 1994) (alleging FDCA violation); United States v. Sene X Eleemosynary Corp., 479 F. Supp. 970, 980-81 (S.D. Fla. 1979) ("Where an injunction is authorized by statute, it is proper to issue such an order to restrain violations of the......